Shps Prima Medi

Shps Prima Medi, a woman-owned limited liability company based in Tbilisi, Georgia, supplies specialized laboratory equipment, diagnostic reagents, and microbiology consumables to the Walter Reed Army Institute of Research and related U.S. military medical research facilities as a prime contractor on full-and-open purchase orders, with no subcontract footprint.

Shps Prima Medi operates entirely as a prime contractor (100% of 18 awards) in a narrow, high-specificity capability domain: procurement and delivery of brand-name laboratory diagnostic equipment and consumable supplies for automated microbial identification, molecular testing, and genomics analysis. Recent representative work includes a $238.027 thousand firm-fixed-price purchase order awarded by the Defense Health Agency in May 2025 for a VITEK MS PRIME automated microbial identification system; a $192.641 thousand blanket purchase order from DARPA in July 2026 for 35 line items of laboratory reagents, culture media, and diagnostic test kits (VITEK systems, VIASURE PCR kits, extraction kits, collection materials) for WRAIR; a $98.477 thousand DARPA purchase order from August 2025 for specialized reagents and consumables compatible with BioMérieux Vitek MS Prime, Vitek 2, and BioFire FilmArray systems; and a $96.198 thousand DARPA purchase order from July 2026 for a QIAcuity One 5 Plex laboratory device with installation, training, and one-year global support. Work is concentrated on performance in Georgia, with deliveries to the U.S. Embassy in Tbilisi supporting WRAIR surveillance and testing operations.

Customer concentration is moderate but agency-specific. The top five funding agencies account for 94% of awards by count and 100% of combined potential value: DARPA leads with 8 awards ($678 thousand), followed by the Defense Health Agency (3 awards, $333 thousand), the Department of State U.S. Embassy Tbilisi (3 awards, $87 thousand), the Department of the Navy Bureau of Medicine and Surgery (2 awards, $52 thousand), and the Department of the Army European Command (1 award, $53 thousand). The source indicates prior contract awards totaling approximately $465 thousand from these agencies since 2017, suggesting sustained but limited-volume engagement over nearly a decade.

Activity has been sparse and episodic: one award each in 2021 and 2022, none in 2023, two in 2025, and three in 2026. Combined potential value across all 18 awards stands at $1.2 million, fully obligated. Two awards (combined potential value $228 thousand) reach ultimate completion within the next twenty-four months, positioning modest recompete exposure. The vendor's category concentration clusters around analytical laboratory instrument manufacturing (5 awards) and medical laboratories (4 awards), with PSC activity dominated by Laboratory Equipment and Supplies (10 awards) and Drugs and Biologicals (2 awards).